Morepen Labs gets USFDA nod for asthma drug

| Dec 20, 2017, 03:29:39 PM | ET Now
  • Share
Morepen Laboratories said the US health regulator has given approval to Montelukast Sodium, used in managing asthma symptoms and seasonal allergies, for sale in the US market. Morepen said patent for Montelukast has expired in all markets worldwide. Morepen is the market leader for Montelukast in India with over 50 per cent market share, supplying to almost all major finished dosage manufacturers in India.